Forte Biosciences director exercises 1,250 RSUs
Forte Biosciences, Inc. director and officer Paul A. Wagner reported routine equity compensation activity.
Rhea-AI Filing Summary
Forte Biosciences, Inc. director and officer Paul A. Wagner reported routine equity compensation activity. On April 1, 2026, 1,250 restricted stock units vested and were exercised into an equal number of common shares at a stated price of $0.00 per share.
To cover tax obligations on this vesting, 98 common shares were withheld at $24.86 per share, a non-market tax-withholding disposition rather than an open-market sale. After these transactions, Wagner directly holds 84,330 common shares and 3,750 RSUs, reflecting a net increase in his equity position.
The RSUs vest in installments, with one-sixteenth of the award vesting on each Quarterly Vesting Date—January 1, April 1, July 1, and October 1—under the company’s 2021 Equity Incentive Plan, so similar compensation-related transactions may continue as future tranches vest.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,250 shares exercised/converted
Exercise
3 txns
Insider
Wagner Paul A.
Role
SEE REMARKS
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,250 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,250 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 98 | $24.86 | $2K |
Holdings After Transaction:
Restricted Stock Units — 3,750 contracts (Direct);
Common Stock — 84,330 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Forte Biosciences, Inc. (the "Issuer") Common Stock.
- F2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, "Quarterly Vesting Date" with respect to any calendar year means January 1, April 1, July 1, and October 1.
Key Figures
RSUs exercised: 1,250 units
Tax-withholding shares: 98 shares at $24.86
Common shares after transaction: 84,330 shares
+2 more
5 metrics
RSUs exercised
1,250 units
Restricted Stock Units converted to common stock on April 1, 2026
Tax-withholding shares
98 shares at $24.86
Shares delivered to cover tax liability on RSU vesting
Common shares after transaction
84,330 shares
Direct Forte Biosciences common stock held by Wagner after April 1, 2026
RSUs remaining
3,750 units
Restricted stock units held after the reported vesting and exercise
Quarterly vesting fraction
1/16 per date
One-sixteenth of the RSU award vests on each Quarterly Vesting Date
Key Terms
Restricted Stock Units, 2021 Equity Incentive Plan, Quarterly Vesting Date, tax-withholding disposition, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Equity Incentive Plan financial
"Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date"
Quarterly Vesting Date financial
""Quarterly Vesting Date" with respect to any calendar year means January 1, April 1, July 1, and October 1"
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
FAQ
What insider transaction did Forte Biosciences (FBRX) report for Paul A. Wagner?
Forte Biosciences reported that Paul A. Wagner exercised 1,250 restricted stock units into common shares. These RSUs vested under the company’s 2021 Equity Incentive Plan, increasing his direct equity stake through routine compensation rather than an open-market stock purchase.
What are the vesting terms of Paul A. Wagner’s Forte Biosciences (FBRX) RSUs?
The RSUs vest in 16 equal installments, with one-sixteenth vesting on each Quarterly Vesting Date. Quarterly Vesting Dates are January 1, April 1, July 1, and October 1, provided Wagner continues as a Service Provider under the 2021 Equity Incentive Plan.
How many Forte Biosciences (FBRX) RSUs did Paul A. Wagner exercise in this transaction?
He exercised 1,250 restricted stock units, converting them into 1,250 shares of Forte Biosciences common stock at a stated exercise price of $0.00 per share. This reflects a scheduled vesting event under his equity award, not a market purchase.
What does the tax-withholding disposition mean in the Forte Biosciences (FBRX) Form 4?
The tax-withholding disposition shows that 98 shares were delivered at $24.86 per share to cover tax liabilities on the RSU vesting. This reduces the number of new shares Wagner receives but does not represent an open-market sale or change in investment outlook.
AI-generated analysis. How Rhea-AI works. Not financial advice.
